Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
A Phase IIIb, Randomized, Double-Blind, Parallel Group Study in Bipolar I Patients to Assess the Efficacy and Safety of SPD417 Administered Once Daily vs Twice Daily in the Treatment of Manic Symptoms
This study has finished and is no longer accepting participants.
Location not clearly listedQuetiapine Plus Topiramate or Placebo for Bipolar Mania & Alcohol Use in Adolescents & Young Adults
This study has finished and is no longer accepting participants.
In Cincinnati
Efficacy of an Innovative E-neurocognitive Module as Adjunct to Functional Remediation for Bipolar Disorder
This study has finished and is no longer accepting participants.
In BarcelonaThis study evaluated the effectiveness of Quetiapine for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Barcelona52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Birmingham
Emotion Recognition Modification for Bipolar Disorder
This study was withdrawn before enrollment.
In Glen OaksEmotion Regulation Group Therapy for Bipolar Disorder
This study has finished and is no longer accepting participants.
In BostonEpidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
This study has finished and is no longer accepting participants.
Multiple locations, including Las PalmasEvaluating the Effectiveness of Imagery Focussed Therapy in Patients Suffering From Bipolar Disorder: an Exploratory Trial
This study has finished and is no longer accepting participants.
In EindhovenEvaluation of a Prevention Program in Children and Teenagers at High Risk for Bipolar Disorder
This study ended early.
Location not clearly listedEvaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
This study has finished and is no longer accepting participants.
Multiple locations, including AdanaA 50-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Subjects With Acute Manic or Mixed Episodes Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.